SCHEMBL17897752

SCHEMBL17897752

Cc1cc(C(=O)NC(=S)Nc2c(O)cc(C)c(Br)c2C)cc(C(F)(F)F)c1

nearest known ligand 0.79

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ AKT1 P31749 6/20 0.79
▸ ALDH1A1 P00352 6/20 0.42
▸ CYP1A2 P05177 2/20 0.42
▸ LMNA P02545 2/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ MAPT P10636 3/20 0.40
▸ ALOX12 P18054 3/20 0.40
▸ PDPK1 O15530 2/20 0.40
▸ NPSR1 Q6W5P4 2/20 0.40
▸ CYTH3 O43739 1/20 0.39
▸ P2RX4 Q99571 2/20 0.38
▸ P2RX7 Q99572 2/20 0.38
▸ GAA P10253 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ PLA2G1B P04054 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ ATG4B Q9Y4P1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15778541 0.95 AKT1 (0.73) AKT1ALDH1A1CYP1A2ALOX12NPSR1
SCHEMBL351989 0.89 AKT1 (1.00) AKT1ALDH1A1LMNASMN1; SMN2MAPT
SCHEMBL17897769 0.87 AKT1 (0.77) AKT1ALDH1A1CYP1A2LMNASMN1; SMN2
SCHEMBL17897745 0.83 AKT1 (0.82) AKT1ALDH1A1CYP1A2LMNASMN1; SMN2
SCHEMBL15778482 0.80 AKT1 (0.63) AKT1ALDH1A1CYP1A2LMNASMN1; SMN2
SCHEMBL351879 0.79 AKT1 (1.00) AKT1ALDH1A1CYP1A2LMNASMN1; SMN2
SCHEMBL15778845 0.78 AKT1 (0.81) AKT1ALDH1A1LMNASMN1; SMN2MAPT
SCHEMBL17897746 0.77 AKT1 (0.64) AKT1ALDH1A1CYP1A2LMNAMAPT
SCHEMBL17897754 0.77 AKT1 (0.61) AKT1ALDH1A1CYP1A2LMNAMAPT
SCHEMBL352146 0.76 AKT1 (1.00) AKT1ALDH1A1LMNASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160194279-A1 ONE POT PROCESS FOR THE CONVERSION OF AROYL CHLORIDES TO ACYL THIOUREAS COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2016-07-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160194279-A1 ONE POT PROCESS FOR THE CONVERSION OF AROYL CHLORIDES TO ACYL THIOUREAS TRRAP, NAT1, AHR AKT1 2603/4885ALDH1A1 445/4885CYP1A2 222/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback